Log in
Enquire now
‌

US Patent 10666592 RNA targeting methods and compositions

Patent 10666592 was granted and assigned to Salk Institute for Biological Studies on May, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Salk Institute for Biological Studies
Salk Institute for Biological Studies
Current Assignee
Salk Institute for Biological Studies
Salk Institute for Biological Studies
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10666592
Date of Patent
May 26, 2020
Patent Application Number
16237381
Date Filed
December 31, 2018
Patent Citations Received
‌
US Patent 11970720 RNA targeting methods and compositions
0
‌
US Patent 11310179 RNA targeting methods and compositions
‌
US Patent 11310180 RNA targeting methods and compositions
‌
US Patent 11316812 RNA targeting methods and compositions
‌
US Patent 10931613 RNA targeting methods and compositions
‌
US Patent 11005799 RNA targeting methods and compositions
‌
US Patent 11025574 RNA targeting methods and compositions
‌
US Patent 11032225 RNA targeting methods and compositions
...
Patent Primary Examiner
‌
Celine X Qian
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10666592 RNA targeting methods and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.